UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation Carriers

Canadian Association of Radiologists journal, 2016-11, Vol.67 (4), p.308-312

2016

Volltextzugriff (PDF)

No Evidence of False Reassurance among Women with an Inconclusive BRCA1/2 Genetic Test Result

Cancer epidemiology, biomarkers & prevention, 2005-12, Vol.14 (12), p.2862-2867

2005

Volltextzugriff (PDF)

Effect of the Women's Health Initiative Study Publication on Hormone Replacement Therapy Use among Women Who Have Undergone BRCA1/2 Testing

Cancer epidemiology, biomarkers & prevention, 2007-01, Vol.16 (1), p.157-160

2007

Volltextzugriff (PDF)

Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer

BMC cancer, 2009-06, Vol.9 (181), p.181-181

2009

Volltextzugriff (PDF)

Multidisciplinary clinical management for prophylactic mastectomy: views of women from one centre in Quebec City

Bulletin du cancer, 2013-03, Vol.100 (3), p.201

2013

Volltextzugriff (PDF)

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Breast cancer research : BCR, 2006-01, Vol.8 (1), p.R3-R3, Article R3

2006

Volltextzugriff (PDF)

Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer

Genetic testing and molecular biomarkers, 2010-08, Vol.14 (4), p.515-526

2010

Volltextzugriff (PDF)

Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec

European journal of human genetics : EJHG, 2011-05, Vol.19 (5), p.494-499

2011

Volltextzugriff (PDF)

Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families

Human genetics, 2005-07, Vol.117 (2-3), p.119-132

2005

Volltextzugriff (PDF)

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

British journal of cancer, 2009, Vol.101 (12), p.2048-2054

2009

Volltextzugriff (PDF)

Health Behaviors and Psychological Distress in Women Initiating BRCA1/2 Genetic Testing: Comparison with Control Population

Journal of genetic counseling, 2008-08, Vol.17 (4), p.314-326

2008

Volltextzugriff (PDF)

Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers

Breast cancer research and treatment, 2010-07, Vol.122 (1), p.281-285

2010

Volltextzugriff (PDF)

Changes in health-related behaviours following BRCA 1/2 genetic testing: the case of hormone replacement therapy

Journal of obstetrics and gynaecology Canada, 2004-12, Vol.26 (12), p.1059-1066

2004

Volltextzugriff (PDF)

Clinical Management Recommendations for Surveillance and Risk-Reduction Strategies for Hereditary Breast and Ovarian Cancer Among Individuals Carrying a Deleterious BRCA1 or BRCA2 Mutation

Journal of obstetrics and gynaecology Canada, 2007, Vol.29 (1), p.45-60

2007

Volltextzugriff (PDF)

Changes in Health-Related Behaviours Following BRCA1/2 Genetic Testing: The Case of Hormone Replacement Therapy

Journal of obstetrics and gynaecology Canada, 2004-12, Vol.26 (12), p.1059-1066

2004

Volltextzugriff (PDF)

Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges

Familial cancer, 2006, Vol.5 (1), p.3-13

2006

Volltextzugriff (PDF)

No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families

Genetic testing, 2006-06, Vol.10 (2), p.104-115

2006

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

ThemaGenes, Brca1

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(17)

Sprache

Englisch
(15)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Usefulness of Canadian Public Health Insurance Administrative Databases to Assess Breast and Ovarian Cancer Screening Imaging Technologies for BRCA1/2 Mutation Carriers

No Evidence of False Reassurance among Women with an Inconclusive BRCA1/2 Genetic Test Result

Effect of the Women's Health Initiative Study Publication on Hormone Replacement Therapy Use among Women Who Have Undergone BRCA1/2 Testing

Variations in the NBN/NBS1 gene and the risk of breast cancer in non-BRCA1/2 French Canadian families with high risk of breast cancer

Multidisciplinary clinical management for prophylactic mastectomy: views of women from one centre in Quebec City

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families

Evaluation of the contribution of the three breast cancer susceptibility genes CHEK2, STK11, and PALB2 in non-BRCA1/2 French Canadian families with high risk of breast cancer

Breast and ovarian cancer screening of non-carriers from BRCA1/2 mutation-positive families: 2-year follow-up of cohorts from France and Quebec

Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

Health Behaviors and Psychological Distress in Women Initiating BRCA1/2 Genetic Testing: Comparison with Control Population

Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers

Changes in health-related behaviours following BRCA 1/2 genetic testing: the case of hormone replacement therapy

Clinical Management Recommendations for Surveillance and Risk-Reduction Strategies for Hereditary Breast and Ovarian Cancer Among Individuals Carrying a Deleterious BRCA1 or BRCA2 Mutation

Changes in Health-Related Behaviours Following BRCA1/2 Genetic Testing: The Case of Hormone Replacement Therapy

Partnering in oncogenetic research--the INHERIT BRCAs experience: opportunities and challenges

No Evidence of BRCA1/2 genomic rearrangements in high-risk French-Canadian breast/ovarian cancer families

Aktive Filter

Suchergebnisse filtern